Our prior industry experience as in-house counsel informs our approach to M&A. Our lawyers have negotiated and handled strategic pharmaceutical acquisitions worth over USD 5 Billion, including acquisitions, minority investments, joint ventures and dispositions. Our M&A experience spans every continent except Antartica. Our industry focus gives us an edge in pharmaceutical M&A, when it comes to diligence, structuring and negotiations.